Literature DB >> 18281930

N-substituted 3-acetyltetramic acid derivatives as antibacterial agents.

Raghunandan Yendapally1, Julian G Hurdle, Elizabeth I Carson, Robin B Lee, Richard E Lee.   

Abstract

In order to expand the structure-activity relationship of tetramic acid molecules with structural similarity to the antibiotic reutericyclin, 22 compounds were synthesized and tested against a panel of clinically relevant bacteria. Key structural changes on the tetramic acid core affected antibacterial activity. Various compounds in the N-alkyl 3-acetyltetramic acid series exhibited good activity against Gram-positive bacterial pathogens including Bacillus anthracis, Propionibacterium acnes, Enterococcus faecalis, and both Methicillin-sensitive and -resistant Staphylococcus aureus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18281930     DOI: 10.1021/jm701356q

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  14 in total

1.  Reutericyclin and related analogues kill stationary phase Clostridium difficile at achievable colonic concentrations.

Authors:  Julian G Hurdle; Amy E Heathcott; Lei Yang; Bing Yan; Richard E Lee
Journal:  J Antimicrob Chemother       Date:  2011-05-31       Impact factor: 5.790

2.  Design, synthesis, and evaluation of substituted nicotinamide adenine dinucleotide (NAD+) synthetase inhibitors as potential antitubercular agents.

Authors:  Xu Wang; Yong-Mo Ahn; Adam G Lentscher; Julia S Lister; Robert C Brothers; Malea M Kneen; Barbara Gerratana; Helena I Boshoff; Cynthia S Dowd
Journal:  Bioorg Med Chem Lett       Date:  2017-08-08       Impact factor: 2.823

Review 3.  Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections.

Authors:  Julian G Hurdle; Alex J O'Neill; Ian Chopra; Richard E Lee
Journal:  Nat Rev Microbiol       Date:  2011-01       Impact factor: 60.633

4.  Antibacterial and antitubercular activity of fosmidomycin, FR900098, and their lipophilic analogs.

Authors:  Eugene Uh; Emily R Jackson; Géraldine San Jose; Marcus Maddox; Robin E Lee; Richard E Lee; Helena I Boshoff; Cynthia S Dowd
Journal:  Bioorg Med Chem Lett       Date:  2011-10-05       Impact factor: 2.823

5.  Tetramic and tetronic acids as scaffolds in bioinorganic and bioorganic chemistry.

Authors:  G Athanasellis; O Igglessi-Markopoulou; J Markopoulos
Journal:  Bioinorg Chem Appl       Date:  2010-05-25       Impact factor: 7.778

6.  An ABC transporter of Streptococcus pneumoniae involved in susceptibility to vancoresmycin and bacitracin.

Authors:  Petra Becker; Regine Hakenbeck; Bernhard Henrich
Journal:  Antimicrob Agents Chemother       Date:  2009-03-09       Impact factor: 5.191

7.  Explorations of stemona alkaloid-inspired analogues: skeletal modification and functional group diversification.

Authors:  Kevin J Frankowski; Benjamin Neuenswander; Jeffrey Aubé
Journal:  J Comb Chem       Date:  2008-08-13

8.  Evaluation of analogs of reutericyclin as prospective candidates for treatment of staphylococcal skin infections.

Authors:  Julian G Hurdle; Raghunandan Yendapally; Dianqing Sun; Richard E Lee
Journal:  Antimicrob Agents Chemother       Date:  2009-07-06       Impact factor: 5.191

9.  The membrane as a target for controlling hypervirulent Clostridium difficile infections.

Authors:  Xiaoqian Wu; Philip T Cherian; Richard E Lee; Julian G Hurdle
Journal:  J Antimicrob Chemother       Date:  2012-12-21       Impact factor: 5.790

10.  Defining the mode of action of tetramic acid antibacterials derived from Pseudomonas aeruginosa quorum sensing signals.

Authors:  Colin A Lowery; Junguk Park; Christian Gloeckner; Michael M Meijler; Ryan S Mueller; Helena I Boshoff; Ricky L Ulrich; Clifton E Barry; Douglas H Bartlett; Vladimir V Kravchenko; Gunnar F Kaufmann; Kim D Janda
Journal:  J Am Chem Soc       Date:  2009-10-14       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.